Market Outlook
A number of infectious diseases and the increasing number of resistant strains of microorganisms lead to the development of microbial detection kits. However these traditional methods of culturing and then identification is time consuming. Automated microbial detection systems is one solution for this problem.
Using these systems the detection process of microorganisms can be done within a few minutes of culturing and the results could be available within a couple of hours. Automated microbial detection systems are automated tools used for the detection of key contaminant microorganisms.
These methods allow for preventive controls and faster testing. The results could be obtained within a few hours using the automated microbial detection systems, when compared to the traditional culturing methods.
A number of large and small players provide automated microbial detection systems. Some of them include Thermo Fisher Scientific, Lonza, Pall Corporation, MediRay, BioMeriux and MIDI Inc.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6955
Market Dynamics of Automated Microbial Detection Systems Market
A number of factors drive the growth of the automated microbial detection systems market. Some of these include the increase in incidence of infectious diseases that are coupled with epidemic and pandemic events that occur every year.
Increasing food safety concerns is another factor that drives the growth of the automated microbial detection system market. Technology advancements and government initiatives to aid the development of the market further.
However, high cost of automated microbial detection systems and complex regulatory framework slightly hinder the growth of the automated microbial detection systems market.
Genotypic Methods are Popularizing
When genotypic methods are applied for the identification of microorganisms it results in specie-specific fingerprints. The genotypic methods of automated microbial detection systems are fast and reliable.
New genotypic methods include the use of microchips coated with an array of oligonucleotides that allows rapid identification, by the determination of patterns or sequences that are specific to an organism.
DNA sequencing and biochemical sequencing coupled with fluorescent analysis of the product is also being developed for automation.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6955
Automated Microbial Detection Systems in Diagnostic Laboratories
Diagnostic laboratories culture different kinds of samples such as blood and urine for diagnosis of infectious diseases. With the traditional method of culturing and testing the results could take days and the patient may be in distress until then. There is a need to reduce the time required for the detection process. This can be achieved by the use of automated microbial detection systems.
Regional Market Outlook
Although North America will continue to hold the largest share in the automated microbial detection systems market, Asia-Pacific is expected to grow with the largest CAGR. The continued focus of the major player towards emerging and Asian countries as well as due to the support of the government in these region leads to development of the automated microbial detection systems market in the region.
Competition Outlook
Automated Microbial Detection Systems are expensive devices. Thus the Automated Microbial Detection System Market is dominated by large players like Thermo Fisher Scientific, Becton Dickinson, Merck Millipore and Lonza. The other small players include Biomerieux, MIDI Inc and MediRay.
| Small-Scale Manufacturers/Providers | Medium-Scale Manufacturers/Providers | Large-Scale Manufacturers/Providers |
|---|---|---|
|
|
|
Research Methodology
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology.
Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.
Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-6955
Key data points covered in report
The report covers exhaustive analysis on:
- Automated Microbial Detection Systems Market by technology, end user and region
- Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by technology, end use segments and country
- Automated Microbial Detection Systems Market Dynamics & Opportunity Assessment
- Historical Actual Market Size, 2013 – 2017
- Automated Microbial Detection Systems Market Size & Forecast 2018-2028
- Automated Microbial Detection Systems Market Trends/Issues/Challenges
- Competition & Companies involved
Market Segmentation
By Technology
- Phenotypic Methods
- Genotypic Methods
By End user
- Pharmaceutical and Biotechnology Industry
- Food & Beverages Industries
- Water & Environment Industries
- Diagnostic Laboratories
- Blood Banks
- Hospitals
- Others
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
